10 Dec 2015 Blackmores Institute Six comp meds among therapies in new depression treatment guidelines 10 Dec 2015 Share Share on LinkedIn Share on Facebook Share on Twitter Share on Google+ Share on Pinterest News New clinical practice guidelines issued this month by the Royal Australian and New Zealand College of Psychiatry name omega 3 fatty acids and St John’s Wort among evidence-based complementary therapies used in the management of mood disorders. According to a media statement from RANZCP, the 'Clinical Practice Guidelines for Mood Disorders' bring together the most up-to-date evidence available internationally for treatment of these conditions and will be useful for psychiatrists, psychologists and all specialties within mental health. × To continue reading this article, please Log In or Sign Up for access.